What Is a Stem Cell?
What are the Different Types of Stem Cells?
Multipotent adult stem cells, those derived from bone or adipose tissue, have the ability to divide and generate all cell types of the organ from which they originate. They possess two properties: self-renewal and multi-potency, meaning they can go through numerous cycles of cell division while still maintaining their undifferentiated state. Pluripotent adult stem cells, those derived from the blood, have the ability to divide and generate all cell types and are consider “uncommitted”. These stem cells hold the ability to generate into several distinct cell types, including neural cells found in the brain. Pluripotent stem cells behave like embryonic stem cells and give rise to all the cell types in the body. They endure a long lifespan and work best in combination with PRP. TBI Therapy only uses pluripotent stem cells in efforts to obtain the best results possible! Regenerative stem cell therapy can stimulate tissue re-growth and greater blood flow to the affected areas.* The goal of treatment with stem cells is to replace damaged cells and to promote the growth of new blood vessels and tissues in order to help the target organ function at a greater capacity.* *Results may vary; no guarantee of specific results
What to Know Before Getting Stem Cells
Dr. Hughes presents about the various types of stem cells and what they are best used for including: adult vs embryonic, pluripotent vs multipotent, and blood-based vs. mesenchymal.
Stem Cells for TBI
Join Dr. Hughes during his LIVE webinar as he talks about the benefits of intranasal adult stem cells for the treatment of traumatic brain injury.
Intranasal Stem Cell Procedure
To promote optimal regeneration, stem cell infusions are usually paired with several hyperbaric oxygen therapy (HBOT) sessions before and after. Intranasal PRP is also infused the day before stem cells to enhance the regeneration process.
Stem Cell Technology Used at TBI Therapy
The stem cells are extracted using the Tithon Biotech technology. This patented procedure termed PBD-PSC Technology, is founded in discoveries involving a unique population of pluripotent stem cells. These cells were initially isolated from adipose-tissue (fat), but were later found to originate in bone marrow and distributed in peripheral blood as well as other body fluids. These cells are in abundance in peripheral blood and in reproductive tissue secretions and dissipate in number and function in humans as they age. Tithon Biotech scientists have determined that these cells play a large role in future stem cell based therapeutic applications in both humans and animals.
“Traditionally, inflammation continues to be considered a natural, but sometimes harmful, response to injury, inch said Helen Blau, PhD, professor of microbiology plus immunology and director of Stanford’s Baxter Laboratory intended for Stem Cell Biology. “But we wondered whether there can be a component in the pro-inflammatory signaling cascade that also activated muscle repair. We found that a single exposure to prostaglandin E2 has a profound effect on the proliferation of muscle tissue stem cells in living animals. We postulated that individuals could enhance muscle regeneration by simply augmenting this organic physiological process in existing stem cells already situated along the muscle fiber.”